Philippe Margaron

Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Adrian Koh, Timothy Y. Y. Lai, Kanji Takahashi et al. · JAMA Ophthalmology · 2017 · 291 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Tock Han Lim, Timothy Y. Y. Lai, Kanji Takahashi et al. · JAMA Ophthalmology · 2020 · 162 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD

Sebastian M. Waldstein, Jonathan Wright, James Warburton et al. · Ophthalmology · 2015 · 126 citations · Full text

Medicine, Ophthalmology, Vision Science +17

Release of Cytochrome c, Bax Migration, Bid Cleavage, and Activation of Caspases 2, 3, 6, 7, 8, and 9 during Endothelial Cell Apoptosis

David J. Granville, Janet R. Shaw, Simon Leong et al. · American Journal Of Pathology · 1999 · 107 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Structure‐Photodynamic Activity Relationships of a Series of 4‐Substituted Zinc Phthalocyanines

Philippe Margaron, Marie‐Josée Grégoire, V. Ščasnár et al. · Photochemistry and Photobiology · 1996 · 101 citations

Pharmacy, Pharmacology, Toxicology +16